688 related articles for article (PubMed ID: 31299136)
1. Lactobacilli-containing vaginal probiotics to cure or prevent bacterial or fungal vaginal dysbiosis: a systematic review and recommendations for future trial designs.
van de Wijgert J; Verwijs MC
BJOG; 2020 Jan; 127(2):287-299. PubMed ID: 31299136
[TBL] [Abstract][Full Text] [Related]
2. Impact of
Mändar R; Sõerunurk G; Štšepetova J; Smidt I; Rööp T; Kõljalg S; Saare M; Ausmees K; Le DD; Jaagura M; Piiskop S; Tamm H; Salumets A
Benef Microbes; 2023 Apr; 14(2):143-152. PubMed ID: 36856121
[TBL] [Abstract][Full Text] [Related]
3. Vaginal microbiota of asymptomatic bacterial vaginosis and vulvovaginal candidiasis: Are they different from normal microbiota?
Pramanick R; Mayadeo N; Warke H; Begum S; Aich P; Aranha C
Microb Pathog; 2019 Sep; 134():103599. PubMed ID: 31212037
[TBL] [Abstract][Full Text] [Related]
4. Vaginal colonisation by probiotic lactobacilli and clinical outcome in women conventionally treated for bacterial vaginosis and yeast infection.
Pendharkar S; Brandsborg E; Hammarström L; Marcotte H; Larsson PG
BMC Infect Dis; 2015 Jul; 15():255. PubMed ID: 26137971
[TBL] [Abstract][Full Text] [Related]
5. Probiotics and vaginal microecology: fact or fancy?
Buggio L; Somigliana E; Borghi A; Vercellini P
BMC Womens Health; 2019 Jan; 19(1):25. PubMed ID: 30704451
[TBL] [Abstract][Full Text] [Related]
6. The role of lactic acid production by probiotic Lactobacillus species in vaginal health.
Tachedjian G; Aldunate M; Bradshaw CS; Cone RA
Res Microbiol; 2017; 168(9-10):782-792. PubMed ID: 28435139
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of the association of 2 probiotic strains formulated in a slow release vaginal product, in women affected by vulvovaginal candidiasis: a pilot study.
Vicariotto F; Del Piano M; Mogna L; Mogna G
J Clin Gastroenterol; 2012 Oct; 46 Suppl():S73-80. PubMed ID: 22955364
[TBL] [Abstract][Full Text] [Related]
8. Probiotics for the treatment of bacterial vaginosis.
Senok AC; Verstraelen H; Temmerman M; Botta GA
Cochrane Database Syst Rev; 2009 Oct; (4):CD006289. PubMed ID: 19821358
[TBL] [Abstract][Full Text] [Related]
9. The role of lactobacillus probiotics in the treatment or prevention of urogenital infections--a systematic review.
Abad CL; Safdar N
J Chemother; 2009 Jun; 21(3):243-52. PubMed ID: 19567343
[TBL] [Abstract][Full Text] [Related]
10. Connecting the Dots: Translating the Vaginal Microbiome Into a Drug.
Lagenaur LA; Hemmerling A; Chiu C; Miller S; Lee PP; Cohen CR; Parks TP
J Infect Dis; 2021 Jun; 223(12 Suppl 2):S296-S306. PubMed ID: 33330916
[TBL] [Abstract][Full Text] [Related]
11. Vaginal Microbiota.
Mendling W
Adv Exp Med Biol; 2016; 902():83-93. PubMed ID: 27161352
[TBL] [Abstract][Full Text] [Related]
12. Vaginal microbiota and the potential of Lactobacillus derivatives in maintaining vaginal health.
Chee WJY; Chew SY; Than LTL
Microb Cell Fact; 2020 Nov; 19(1):203. PubMed ID: 33160356
[TBL] [Abstract][Full Text] [Related]
13. Impact of a lactobacilli-containing gel on vulvovaginal candidosis and the vaginal microbiome.
Oerlemans EFM; Bellen G; Claes I; Henkens T; Allonsius CN; Wittouck S; van den Broek MFL; Wuyts S; Kiekens F; Donders GGG; Lebeer S
Sci Rep; 2020 May; 10(1):7976. PubMed ID: 32409699
[TBL] [Abstract][Full Text] [Related]
14. Lactobacillus plantarum P17630 for preventing Candida vaginitis recurrence: a retrospective comparative study.
De Seta F; Parazzini F; De Leo R; Banco R; Maso GP; De Santo D; Sartore A; Stabile G; Inglese S; Tonon M; Restaino S
Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():136-9. PubMed ID: 25305660
[TBL] [Abstract][Full Text] [Related]
15. Use of Lactobacillus probiotics for bacterial genitourinary infections in women: a review.
Barrons R; Tassone D
Clin Ther; 2008 Mar; 30(3):453-68. PubMed ID: 18405785
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of the two microorganisms Lactobacillus fermentum LF15 and Lactobacillus plantarum LP01, formulated in slow-release vaginal tablets, in women affected by bacterial vaginosis: a pilot study.
Vicariotto F; Mogna L; Del Piano M
J Clin Gastroenterol; 2014; 48 Suppl 1():S106-12. PubMed ID: 25291116
[TBL] [Abstract][Full Text] [Related]
17. The Need to Focus on Therapy Instead of Associations.
Reid G
Front Cell Infect Microbiol; 2019; 9():327. PubMed ID: 31572693
[TBL] [Abstract][Full Text] [Related]
18. Restoring vaginal microbiota: biological control of bacterial vaginosis. A prospective case-control study using Lactobacillus rhamnosus BMX 54 as adjuvant treatment against bacterial vaginosis.
Recine N; Palma E; Domenici L; Giorgini M; Imperiale L; Sassu C; Musella A; Marchetti C; Muzii L; Benedetti Panici P
Arch Gynecol Obstet; 2016 Jan; 293(1):101-107. PubMed ID: 26142892
[TBL] [Abstract][Full Text] [Related]
19. An exploratory pilot study evaluating the supplementation of standard antibiotic therapy with probiotic lactobacilli in south African women with bacterial vaginosis.
Marcotte H; Larsson PG; Andersen KK; Zuo F; Mikkelsen LS; Brandsborg E; Gray G; Laher F; Otwombe K
BMC Infect Dis; 2019 Sep; 19(1):824. PubMed ID: 31533663
[TBL] [Abstract][Full Text] [Related]
20. Testing the regulatory framework in South Africa - a single-blind randomized pilot trial of commercial probiotic supplementation to standard therapy in women with bacterial vaginosis.
Happel AU; Singh R; Mitchev N; Mlisana K; Jaspan HB; Barnabas SL; Passmore JS
BMC Infect Dis; 2020 Jul; 20(1):491. PubMed ID: 32650729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
